Pisani P, Parkin DM, Munoz N, Ferlay J: Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev. 1997, 6: 387-400.
CAS
PubMed
Google Scholar
Pujol FH, Devesa M: Genotypic variability of hepatitis viruses associated with chronic infection and the development of hepatocellular carcinoma. J Clin Gastroenterol. 2005, 39: 611-618. 10.1097/01.mcg.0000170770.49394.92.
CAS
PubMed
Google Scholar
Ord RA, Blanchaert RH: Current management of oral cancer. A multidisciplinary approach. J Am Dent Assoc. 2001, 132 (Suppl): 19S-23S.
PubMed
Google Scholar
Crowe SE: Helicobacter infection, chronic inflammation, and the development of malignancy. Curr Opin Gastroenterol. 2005, 1: 32-8.
Google Scholar
Montalban C, Santon A, Boixeda D, Bellas C: Regression of gastric high grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication. Gut. 2001, 49: 584-587. 10.1136/gut.49.4.584.
PubMed Central
CAS
PubMed
Google Scholar
Persing DH, Prendergast FG: Infection, immunity, and cancer. Arch Pathol Lab Med. 1999, 123: 1015-1022.
CAS
PubMed
Google Scholar
Vaishnavi C, Kochhar R, Singh G, Kumar S, Singh S, Singh K: Epidemiology of typhoid carriers among blood donors and patients with biliary, gastrointestinal and other related diseases. Microbiol Immunol. 2005, 49: 107-112.
CAS
PubMed
Google Scholar
Lax AJ, Thomas W: How bacteria could cause cancer: one step at a time. Trends Microbiol. 2002, 10: 293-9. 10.1016/S0966-842X(02)02360-0.
CAS
PubMed
Google Scholar
Dutta U, Garg PK, Kumar R, Tandon RK: Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am J Gastroenterol. 2000, 95: 784-787. 10.1111/j.1572-0241.2000.01860.x.
CAS
PubMed
Google Scholar
Shukla VK, Singh H, Pandey M, Upadhyay SK, Nath G: Carcinoma of the gallbladder – is it a sequel of typhoid?. Dig Dis Sci. 2000, 45: 900-903. 10.1023/A:1005564822630.
CAS
PubMed
Google Scholar
Biarc J, Nguyen IS, Pini A, Gosse F, Richert S, Thierse D, Van DA, Leize-Wagner E, Raul F, Klein JP, Scholler-Guinard M: Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S. bovis). Carcinogenesis. 2004, 25: 1477-1484. 10.1093/carcin/bgh091.
CAS
PubMed
Google Scholar
Gold JS, Bayar S, Salem RR: Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg. 2004, 139: 760-765. 10.1001/archsurg.139.7.760.
PubMed
Google Scholar
Ellmerich S, Scholler M, Duranton B, Gosse F, Galluser M, Klein JP, Raul F: Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis. 2000, 21: 753-756. 10.1093/carcin/21.4.753.
CAS
PubMed
Google Scholar
Zarkin BA, Lillemoe KD, Cameron JL, Effron PN, Magnuson TH, Pitt HA: The triad of Streptococcus bovis bacteremia, colonic pathology, and liver disease. Ann Surg. 1990, 211: 786-791.
PubMed Central
CAS
PubMed
Google Scholar
Littman AJ, White E, Jackson LA, Thornquist MD, Gaydos CA, Goodman GE, Vaughan TL: Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomarkers Prev. 2004, 13: 1624-1630.
PubMed
Google Scholar
Koyi H, Branden E, Gnarpe J, Gnarpe H, Steen B: An association between chronic infection with Chlamydia pneumoniae and lung cancer. A prospective 2-year study. APMIS. 2001, 109: 572-580. 10.1034/j.1600-0463.2001.d01-177.x.
CAS
PubMed
Google Scholar
Anttila T, Koskela P, Leinonen M, Laukkanen P, Hakulinen T, Lehtinen M, Pukkala E, Paavonen J, Saikku P: Chlamydia pneumoniae infection and the risk of female early-onset lung cancer. Int J Cancer. 2003, 107: 681-682. 10.1002/ijc.11353.
CAS
PubMed
Google Scholar
Kuper H, Adami HO, Trichopoulos D: Infections as a major preventable cause of human cancer. J Intern Med. 2000, 248: 171-83. 10.1046/j.1365-2796.2000.00742.x.
CAS
PubMed
Google Scholar
Kocazeybek B: Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: a case-control study. J Med Microbiol. 2003, 52: 721-726. 10.1099/jmm.0.04845-0.
PubMed
Google Scholar
Nougayrede JP, Taieb F, De Rycke J, Oswald E: Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol. 2005, 13: 103-110. 10.1016/j.tim.2005.01.002.
CAS
PubMed
Google Scholar
Lara-Tejero M, Galán JE: A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science. 2000, 290: 354-357. 10.1126/science.290.5490.354.
CAS
PubMed
Google Scholar
Schoppmann SF, Birner P, Stockl J, Kalt R, Ullrich R, Caucig C, Kriehuber E, Nagy K, Alitalo K, Kerjaschki D: Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol. 2002, 161: 947-956.
PubMed Central
CAS
PubMed
Google Scholar
Baik SC, Youn HS, Chung MH, Lee WK, Cho MJ, Ko GH, Park CK, Kasai H, Rhee KH: Increased oxidative DNA damage in Helicobacter pylori infected human gastric mucosa. Cancer Res. 1996, 56: 1279-1282.
CAS
PubMed
Google Scholar
Sheng H, Shao J, Washington MK, DuBois RN: Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem. 2001, 276: 18075-18081. 10.1074/jbc.M009689200.
CAS
PubMed
Google Scholar
Mannick EE, Bravo LE, Zarama G, Realpe JL, Zhang XJ, Ruiz B, Fontham ET, Mera R, Miller MJ, Correa P: Inducible nitric oxide synthase, nitrotyrosine and apoptosis in Helicobacter pylori gastritis: effects of antibiotics and antioxidants. Cancer Res. 1996, 56: 3238-3243.
CAS
PubMed
Google Scholar
Lazcano-Ponce EC, Miquel JF, Munoz N, Herrero R, Ferrecio C, Wistuba II, Alonso de Ruiz P, Aristi UG, Nervi F: Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001, 51: 349-364.
CAS
PubMed
Google Scholar
Levin B: Gallbladder carcinoma. Ann Oncol. 1999, 10 (Suppl 4): 129-130. 10.1023/A:1008325911628.
PubMed
Google Scholar
Wistuba II, Gazdar AF: Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer. 2004, 4: 695-706. 10.1038/nrc1429.
CAS
PubMed
Google Scholar
Randi G, Franceschi S, La Vecchia C: Gallbladder cancer worldwide: Geographical distribution and risk factors. Int J Cancer. 2006, 118: 159-602. 10.1002/ijc.21683.
Google Scholar
Caygill CP, Hill MJ, Braddick M, Sharp JC: Cancer mortality in chronic typhoid and paratyphoid carriers. Lancet. 1994, 343: 83-4. 10.1016/S0140-6736(94)90816-8.
CAS
PubMed
Google Scholar
Welton JC, Marr JS, Friedman SM: Association between hepatobiliary cancer and typhoid carrier state. Lancet. 1979, 1: 791-794. 10.1016/S0140-6736(79)91315-1.
CAS
PubMed
Google Scholar
Miquel JF, Covarrubias C, Villaroel L, Mingrone G, Greco AV, Puglielli L, Carvallo P, Marshall G, Del PG, Nervi F: Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology. 1998, 115: 937-946. 10.1016/S0016-5085(98)70266-5.
CAS
PubMed
Google Scholar
Paltoo DN, Chu KC: Patterns in cancer incidence among American Indians/Alaska Natives, United States, 1992–1999. Public Health Rep. 2004, 119: 443-451. 10.1016/j.phr.2004.05.009.
PubMed Central
PubMed
Google Scholar
Strom BL, Soloway RD, Rios-Dalenz JL, Rodriguez-Martinez HA, West SL, Kinman JL, Polansky M, Berlin JA: Risk factors for gallbladder cancer. An international collaborative case-control study. Cancer. 1995, 76: 1747-1756.
CAS
PubMed
Google Scholar
Chianale J, Del Pino G, Nervi F: Increasing gall-bladder cancer mortality rate during the last decade in Chile, a high-risk area. Int J Cancer. 1990, 46: 1131-1133.
CAS
PubMed
Google Scholar
Wood R, Fraser LA, Brewster DH, Garden OJ: Epidemiology of gallbladder cancer and trends in cholecystectomy rates in Scotland, 1968–1998. Eur J Cancer. 2003, 39: 2080-2086. 10.1016/S0959-8049(03)00370-8.
CAS
PubMed
Google Scholar
Centers for Disease Control. [http://www.cdc.gov/lungcancer/statistics/index.htm]
SEER Cancer Statistics Review, 1975-2002, . Edited by: Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Feuer EJ, Edwards BK. National Cancer Institute. Bethesda, MD
Grant SC, Kris MG, Houghton AN, Chapman PB: Long Survival of Patients with Small Cell Lung Cancer after Adjuvant Treatment with the Anti-Idiotypic Antibody BEC2 Plus Bacillus Calmette-Guérin. Clin Cancer Res. 1999, 5: 1319-1323.
CAS
PubMed
Google Scholar
Laurila AL, Von Hertzen L, Saikku P: Chlamydia pneumoniae and chronic lung diseases. Scand J Infect Dis. 1997, 104 (Suppl): 34-36.
CAS
Google Scholar
Hahn DL, Azenabor AA, Beatty WL, Byrne GI: Chlamydia pneumoniae as a respiratory pathogen. Front Biosci. 2002, 7: e66-76.
CAS
PubMed
Google Scholar
Littman AJ, Thornquist MD, White E, Jackson LA, Goodman GE, Vaughan TL: Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes Control. 2004, 15: 819-27. 10.1023/B:CACO.0000043432.71626.45.
PubMed
Google Scholar
Huycke MM, Gaskins HR: Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med. 2004, 229: 586-97.
CAS
Google Scholar
Cohen AM, Minsky BD, Schilsky RL: Cancer of the colon. Cancer: principles and practice of oncology. Edited by: DeVita VT, Hellman S, Rosenberg SA. 1997, Philadelphia: Lippincott-Raven, 1144-1197. 5
Google Scholar
Colon Cancer Alliance: Colorectal cancer: facts and figures. 2001
Google Scholar
Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, Englyst H, Williams HF, Rhodes JM: Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology. 2004, 127: 80-93. 10.1053/j.gastro.2004.03.054.
CAS
PubMed
Google Scholar
Kim NH, Park JP, Jeon SH, Lee YJ, Choi HJ, Jeong KM, Lee JG, Choi SP, Lim JH, Kim YH, Kim YS, Kim YM, Hwang MH, Cho JW, Moon Y, Oh SK, Jeong JW: Purulent pericarditis caused by group G streptococcus as an initial presentation of colon cancer. J Korean Med Sci. 2002, 17: 571-573.
PubMed Central
PubMed
Google Scholar
Siegert CE, Overbosch D: Carcinoma of the colon presenting as Streptococcus sanguis bacteremia. Am J Gastroenterol. 1995, 90: 1528-1529.
CAS
PubMed
Google Scholar
McCoy WC, Mason JM: Enterococcal endocarditis associated with carcinoma of the sigmoid; report of a case. J Med Assoc State Ala. 1951, 21: 162-166.
CAS
PubMed
Google Scholar
Roses DF, Richman H, Localio SA: Bacterial endocarditis associated with colorectal carcinoma. Ann Surg. 1974, 179: 190-191.
PubMed Central
CAS
PubMed
Google Scholar
Bayliss R, Clarke C, Oakley CM, Somerville W, Whitfield AG, Young SE: The bowel, the genitourinary tract, and infective endocarditis. Br Heart J. 1984, 51: 339-345.
PubMed Central
CAS
PubMed
Google Scholar
Bayliss R, Clarke C, Oakley CM, Somerville W, Whitfield AG, Young SE: The microbiology and pathogenesis of infective endocarditis. Br Heart J. 1983, 50: 513-519.
PubMed Central
CAS
PubMed
Google Scholar
Burns CA, McCaughey R, Lauter CB: The association of Streptococcus bovis fecal carriage and colon neoplasia: possible relationship with polyps and their premalignant potential. Am J Gastroenterol. 1985, 80: 42-46.
CAS
PubMed
Google Scholar
Tsujii M, DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 1995, 83: 493-501. 10.1016/0092-8674(95)90127-2.
CAS
PubMed
Google Scholar
Gately S: The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev. 2000, 19: 19-27. 10.1023/A:1026575610124.
CAS
PubMed
Google Scholar
Munkholm P: Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2003, 18 (Suppl 2): 1-5. 10.1046/j.1365-2036.18.s2.2.x.
PubMed
Google Scholar
Choi PM, Zelig MP: Similarity of colorectal cancer in CD and UC. Implications for carcinogenesis and prevention. Gut. 1994, 35: 950-954.
PubMed Central
CAS
PubMed
Google Scholar
Langholz E, Munkholm P, Davidsen M, Binder V: Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology. 1992, 103: 1444-1451.
CAS
PubMed
Google Scholar
Aspinall RJ: Are adherent Escherichia coli in Crohn's disease and colon cancer truly pathogenic?. Gastroenterol. 2004, 127: 1649-1650. 10.1053/j.gastro.2004.09.072.
Google Scholar
Masseret E, Boudeau J, Colombel JF, Neut C, Desreumaux P, Joly B, Cortot A, Darfeuille-Michaud A: Genetically related Escherichia coli strains associated with Crohn's disease. Gut. 2001, 48: 320-325. 10.1136/gut.48.3.320.
PubMed Central
CAS
PubMed
Google Scholar
de Jong R, Altare F, Haagen IA, Elferink DG, Boer T, van Breda Vriesman PJ, Kabel PJ, Draaisma JM, van Dissel JT, Kroon FP, Casanova JL, Ottenhoff TH: Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science. 1998, 280: 1435-1438. 10.1126/science.280.5368.1435.
CAS
PubMed
Google Scholar
Shibata T, Uryu S, Kokubu A, Hosoda F, Ohki M, Sakiyama T, Matsuno Y, Tsuchiya R, Kanai Y, Kondo T, Imoto I, Inazawa J, Hirohashi S: Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features. Clin Cancer Res. 2005, 11: 6177-6185. 10.1158/1078-0432.CCR-05-0293.
CAS
PubMed
Google Scholar
Oswald E, Sugai M, Labigne A, Wu HC, Fiorentini C, Boquet P, O'Brien AD: Cytotoxic necrotizing factor type 2 produced by virulent Escherichia coli modifies the small GTP-binding proteins Rho involved in assembly of actin stress fibers. Proc Natl Acad Sci U S A. 1994, 91: 3814-3818. 10.1073/pnas.91.9.3814.
PubMed Central
CAS
PubMed
Google Scholar
Fiorentini C, Matarrese P, Straface E, Falzano L, Fabbri A, Donelli G, Cossarizza A, Boquet P, Malorni W: Toxin-induced activation of Rho GTP-binding protein increases Bcl-2 expression and influences mitochondrial homeostasis. Exp Cell Res. 1998, 242: 341-350. 10.1006/excr.1998.4057.
CAS
PubMed
Google Scholar
Haghjoo E, Galán JE: Salmonella typhi encodes a functional cytolethal distending toxin that is delivered into host cells by a bacterial-internalization pathway. Proc Natl Acad Sci U S A. 2004, 101: 4614-4619. 10.1073/pnas.0400932101.
PubMed Central
CAS
PubMed
Google Scholar
Marches O, Ledger TN, Boury M, Ohara M, Tu X, Goffaux F, Mainil J, Rosenshine I, Sugai M, De Rycke J, Oswald E: Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol Microbiol. 2003, 50: 1553-1567. 10.1046/j.1365-2958.2003.03821.x.
CAS
PubMed
Google Scholar
Kilian M: Degradation of immunoglobulins A2, A2, and G by suspected principal periodontal pathogens. Infect Immun. 1981, 34: 757-765.
PubMed Central
CAS
PubMed
Google Scholar
Shurin SB, Socransky SS, Sweeney E, Stossel TP: A neutrophil disorder induced by capnocytophaga, a dental micro-organism. N Engl J Med. 1979, 301: 849-854.
CAS
PubMed
Google Scholar
Mulvey MA, Schilling JD, Hultgren SJ: Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun. 2001, 69: 4572-4579. 10.1128/IAI.69.7.4572-4579.2001.
PubMed Central
CAS
PubMed
Google Scholar
Williams P, Chaudhry Y, Goodfellow IG, Billington J, Powell R, Spiller OB, Evans DJ, Lea S: Mapping CD55 function. J Biol Chem. 2003, 278: 10691-10696. 10.1074/jbc.M212561200.
CAS
PubMed
Google Scholar
Pham T, Kaul A, Hart A, Goluszko P, Moulds J, Nowicki S, Lublin DM, Nowicki BJ: dra-related X adhesins of gestational pyelonephritis-associated Escherichia coli recognize SCR-3 and SCR-4 domains of recombinant decay-accelerating factor. Infect Immun. 1995, 63: 1663-1668.
PubMed Central
CAS
PubMed
Google Scholar
Nowicki B, Selvarangan R, Nowicki S: Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness. J Infect Dis. 2001, 183 (Suppl 1): S24-S27. 10.1086/318846.
PubMed
Google Scholar
The Oral Cancer Foundation. [http://www.oralcancerfoundation.org/facts/]
SEER: Surveillance Epidemiology and End Results. Cancer Statistics Review. 2002, US Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, MD
Google Scholar
Silverman S: Oral cancer. Semin Dermatol. 2001, 13: 132-137.
Google Scholar
Canto MT, Devesa SS: Oral cavity and pharynx cancer incidence rates in the United States 1975–1998. Oral Oncol. 2002, 38: 610-617. 10.1016/S1368-8375(01)00109-9.
PubMed
Google Scholar
Homann N, Tillonen J, Meurman JH, Rintamaki H, Lindqvist C, Rautio M, Jousimies-Somer H, Salaspuro M: Increased salivary acetaldehyde levels in heavy drinkers and smokers: a microbiological approach to oral cavity cancer. Carcinogenesis. 2000, 21: 663-668. 10.1093/carcin/21.4.663.
CAS
PubMed
Google Scholar
World Health Organization: World Health Report. 1996, Geneva
Google Scholar
Alfano MC, Horowitz AM: Professional and community efforts to prevent morbidity and mortality from oral cancer. J Am Dent Assoc. 2001, 24S-29S. Suppl 132
Neville BW, Day TA: Oral cancer and precancerous lesions. CA: Cancer J Clin. 2002, 52: 195-215.
Google Scholar
Holmes JD, Dierks EJ, Homer LD, Potter BE: Is detection of oral and oropharyngeal squamous cancer by a dental health care provider associated with a lower stage at diagnosis?. J Oral Maxillofac Surg. 2003, 61: 285-291. 10.1053/joms.2003.50056.
PubMed
Google Scholar
National Institute of Dental and Craniofacial Research, Oral Cancer Confronting the Enemy. 2003, [http://www.nidcr.nih.gov/HealthInformation/DiseasesAndConditions/SpectrumSeries/OralCancerEnemy.htm]
Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR, Goodson JM: The salivary microbiota as a diagnostic indicator of oral cancer: A descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med. 2005, 3: 27-10.1186/1479-5876-3-27.
PubMed Central
CAS
PubMed
Google Scholar
Nagy KN, Sonkodi I, Szoke I, Nagy E, Newman HN: The microflora associated with human oral carcinomas. Oral Oncology. 1998, 34: 304-308. 10.1016/S1368-8375(98)00008-6.
CAS
PubMed
Google Scholar
Sasaki H, Igaki H, Ishizuka T, Kogoma Y, Sugimura T, Terada M: Presence of streptococcus DNA sequence in surgical specimens of gastric cancer. J Cancer Res. 1995, 86: 791-794.
CAS
Google Scholar
Morita E, Narikiyo M, Yano A, Nishimura E, Igaki H, Sasaki H, Terada M, Hanada N, Kawabe R: Different frequencies of Streptococcus anginosus infection in oral cancer and esophageal cancer. Cancer Sci. 2003, 94: 492-496. 10.1111/j.1349-7006.2003.tb01471.x.
CAS
PubMed
Google Scholar
Mager DL, Ximenez-Fyvie LA, Haffajee AD, Socransky SS: Distribution of selected bacterial species on intraoral surfaces. J Clin Periodontol. 2003, 30: 644-54. 10.1034/j.1600-051X.2003.00376.x.
PubMed
Google Scholar
Sojar HT, Sharma A, Genco RJ: Porphyromonas gingivalis fimbriae bind to cytokeratin of epithelial cells. Infect Immun. 2002, 70: 96-101. 10.1128/IAI.70.1.96-101.2002.
PubMed Central
CAS
PubMed
Google Scholar
Khlgatian M, Nassar H, Chou HH, Gibson FC, Genco CA: Fimbria-dependent activation of cell adhesion molecule expression in Porphyromonas gingivalis-infected endothelial cells. Infect Immun. 2002, 70: 257-267. 10.1128/IAI.70.1.257-267.2002.
PubMed Central
CAS
PubMed
Google Scholar
Weiss EI, Shaniztki B, Dotan M, Ganeshkumar N, Kolenbrander PE, Metzger Z: Attachment of Fusobacterium nucleatum PK1594 to mammalian cells and its coaggregation with periodontopathogenic bacteria are mediated by the same galactose-binding adhesin. Oral Microbiol Immunol. 2000, 15: 371-377. 10.1034/j.1399-302x.2000.150606.x.
CAS
PubMed
Google Scholar
Mergenhagen SE, Sandberg AL, Chassy BM, Brennan MJ, Yeung MK, Donkersloot JA, Cisar JO: Molecular basis of bacterial adhesion in the oral cavity. Rev Infect Dis. 1987, 9: S467-474.
CAS
PubMed
Google Scholar
Neeser JR, Grafstrom RC, Woltz A, Brassart D, Fryder V, Guggenheim B: A 23 kDa membrane glycoprotein bearing NeuNAc alpha 2-3Gal beta 1-3GalNAc O-linked carbohydrate chains acts as a receptor for Streptococcus sanguis OMZ 9 on human buccal epithelial cells. Glycobiology. 1995, 5: 97-104.
CAS
PubMed
Google Scholar
Hakomori S: Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 1996, 56: 5309-5318.
CAS
PubMed
Google Scholar
Bhavanandan VP: Cancer-associated mucins and mucin-type glycoproteins. Glycobiology. 1991, 1: 493-503.
CAS
PubMed
Google Scholar
Richardson MA, Ramirez T, Russell NC, Moye LA: Coley toxins immunotherapy: a retrospective review. Altern Ther Health Med. 1999, 5: 42-47.
CAS
PubMed
Google Scholar
Zacharski LR, Sukhatme VP: Coley's toxin revisited: immunotherapy or plasminogen activator therapy of cancer?. Journal of Thrombosis and Haemostasis. 2005, 3: 424-10.1111/j.1538-7836.2005.01110.x.
CAS
PubMed
Google Scholar
Hoption Cann SA, van Netten JP, van Netten C: Dr William Coley and tumour regression: a place in history or in the future. Postgrad Med J. 2003, 79: 672-680.
PubMed Central
CAS
PubMed
Google Scholar
Sensenig DM, Rossi NP, Ehrenhaft JL: Results of the surgical treatment of bronchogenic carcinoma. Surg Gynecol Obstet. 1963, 116: 279-84.
CAS
PubMed
Google Scholar
Takita H.: Effect of postoperative empyema on survival of patients with bronchogenic carcinoma. J Thorac Cardiovasc Surg. 1970, 59: 642-644.
CAS
PubMed
Google Scholar
Tzankov A, Ludescher C, Duba HC, Steinlechner M, Knapp R, Schmid T, Grunewald K, Gastl G, Stauder R: Spontaneous remission in a secondary acute myelogenous leukaemia following invasive pulmonary aspergillosis. Ann Hematol. 2001, 80: 423-5. 10.1007/s002770100300.
CAS
PubMed
Google Scholar
Hobohm U: Fever and cancer in perspective. Cancer Immunol Immunother. 2001, 50: 391-6.
CAS
PubMed
Google Scholar
Pardoll D: Cancer vaccines. Nat Med. 1998, 4: 525-10.1038/nm0598supp-525.
CAS
PubMed
Google Scholar
Hanson DF: Fever and the immune response. J Immunol. 1993, 151: 436-
CAS
PubMed
Google Scholar
Falk MH, Issels RD: Hyperthermia in oncology. Int J Hyperthermia. 2001, 17: 1-10.1080/02656730150201552.
CAS
PubMed
Google Scholar
Trieb K, Sztankay A, Amberger A, Lechner H, Grubeck-Lobenstein B: Hyperthermia inhibits proliferation and stimulates the expression of differentiation markers in cultured thyroid carcinoma cells. Cancer Lett. 1994, 87: 65-71. 10.1016/0304-3835(94)90410-3.
CAS
PubMed
Google Scholar
Costantini V, Zacharski LR: Fibrin and cancer. Thromb Haemost. 1993, 69: 406-14.
CAS
PubMed
Google Scholar
Zacharski LR, Ornstein DL, Gabazza EC, D'Alessandro-Gabazza CN, Brugarolas A, Schneider J: Treatment of malignancy by activation of the plasminogen system. Semin Thromb Hemost. 2002, 28: 5-18. 10.1055/s-2002-20560.
CAS
PubMed
Google Scholar
Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS, Holland JF, Frei E, Eds: Cancer Medicine. 2003, Hamilton, Ont.: BC Becker Inc
Google Scholar
DeVita VT, Hellman S, Rosenberg SA, eds: Cancer. Principles and Practice of Oncology. 2001, Phildelphia (PA): Lippincott Williams & Wilkins, 6
Uyl-de Groot CA, Vermorken JB, Hanna MG, Verboom P, Groot MT, Bonsel GJ, Meijer CJ, Pinedo HM: Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits. Vaccine. 2005, 23: 2379-2387. 10.1016/j.vaccine.2005.01.015.
CAS
PubMed
Google Scholar
Hoover HC, Brandhorst JS, Peters LC, Surdyke MG, Takeshita Y, Madariaga J, Muenz LR, Hanna MG: Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial. J Clin Oncol. 1993, 11: 390-399.
PubMed
Google Scholar
Nasi ML, Meyers M, Livingston PO, Houghton AN, Chapman PB: Anti-melanoma effects of R24, a monoclonal antibody against GD3 ganglioside. Melanoma Res. 1997, 7 (Suppl 2): S155-S162.
CAS
PubMed
Google Scholar
Chapman PB, Wu D, Ragupathi G, Lu S, Williams L, Hwu WJ, Johnson D, Livingston PO: Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside. Clin Cancer Res. 2004, 10: 4717-4723. 10.1158/1078-0432.CCR-04-0345.
CAS
PubMed
Google Scholar
Giaccone G, Debruyne C, Felip E, Chapman PB, Grant SC, Millward M, Thiberville L, D'addario G, Coens C, Rome LS, Zatloukal P, Masso O, Legrand C: Phase III study of adjuvant vaccination with Bec2/Bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer. J Clin Oncol. 2005, 23: 6854-6864. 10.1200/JCO.2005.17.186.
CAS
PubMed
Google Scholar
Xiang R, Lode HN, Chao TH, Ruehlmann JM, Dolman CS, Rodriguez F, Whitton JL, Overwijk WW, Restifo NP, Reisfeld RA: An autologous oral DNA vaccine protects against murine melanoma. Proc Natl Acad Sci U S A. 2000, 97: 5492-5497. 10.1073/pnas.090097697.
PubMed Central
CAS
PubMed
Google Scholar
Xiang R, Primus FJ, Ruehlmann JM, Niethammer AG, Silletti S, Lode HN, Dolman CS, Gillies SD, Reisfeld RA: A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice. J Immunol. 2001, 167: 4560-4565.
CAS
PubMed
Google Scholar
Niethammer AG, Primus FJ, Xiang R, Dolman CS, Ruehlmann JM, Ba Y, Gillies SD, Reisfeld RA: An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice. Vaccine. 2001, 20: 421-429. 10.1016/S0264-410X(01)00362-0.
CAS
PubMed
Google Scholar
Niethammer AG, Xiang R, Ruehlmann JM, Lode HN, Dolman CS, Gillies SD, Reisfeld RA: Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma. Cancer Res. 2001, 61: 6178-6184.
CAS
PubMed
Google Scholar
Niethammer AG, Xiang R, Becker JC, Wodrich H, Pertl U, Karsten G, Eliceiri BP, Reisfeld RA: A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat Med. 2002, 8: 1369-1375. 10.1038/nm794.
CAS
PubMed
Google Scholar
Parsonnet J: The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther. 1995, 9 (Suppl 2): S45-51.
Google Scholar
Vizcaino AP, Moreno V, Lambert R, Parkin DM: Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995. Int J Cancer. 2002, 99: 860-868. 10.1002/ijc.10427.
CAS
PubMed
Google Scholar
Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, Perez-Perez GI, Schoenberg JB, Stanford JL, Rotterdam H, West AB, Fraumeni JF: An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 1998, 58: 588-590.
CAS
PubMed
Google Scholar
Boulton-Jones JR, Logan RP: An inverse relation between cagA-positive strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Helicobacter. 1999, 4: 281-283. 10.1046/j.1523-5378.1999.99316.x.
CAS
PubMed
Google Scholar
Grimley CE, Holder RL, Loft DE, Morris A, Nwokolo CU: Helicobacter pylori-associated antibodies in patients with duodenal ulcer, gastric and oesophageal adenocarcinoma. Eur J Gastroenterol Hepatol. 1999, 11: 503-509.
CAS
PubMed
Google Scholar
Furuta T, Shirai N, Xiao F, Takashima M, Hanai H: Effect of Helicobacter pylori infection and its eradication on nutrition. Aliment Pharmacol Ther. 2002, 16: 799-806. 10.1046/j.1365-2036.2002.01222.x.
CAS
PubMed
Google Scholar
de Martel C, Llosa AE, Farr SM, Friedman GD, Vogelman JH, Orentreich N, Corley DA, Parsonnet J: Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis. 2005, 191: 761-767. 10.1086/427659.
PubMed
Google Scholar
Lagergren J, Bergstrom R, Nyren O: Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999, 130: 883-890.
CAS
PubMed
Google Scholar
Nwokolo CU, Freshwater DA, O'Hare P, Randeva HS: Plasma ghrelin following cure of Helicobacter pylori. Gut. 2003, 52: 637-640. 10.1136/gut.52.5.637.
PubMed Central
CAS
PubMed
Google Scholar
Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR: Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001, 86: 5992-5995. 10.1210/jc.86.12.5992.
CAS
PubMed
Google Scholar
Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura : A role for ghrelin in the central regulation of feeding. Nature. 2001, 409: 194-198. 10.1038/35051587.
CAS
PubMed
Google Scholar
Nakajima S, Hattori T: Oesophageal adenocarcinoma or gastric cancer with or without eradication of Helicobacter pylori infection in chronic atrophic gastritis patients: a hypothetical opinion from a systematic review. Alimentary Pharmacology & Therapeutics. 2004, 20 (s1): 54-61. 10.1111/j.1365-2036.2004.01975.x.
Google Scholar
Cameron AJ: Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am. 1997, 26: 487-494. 10.1016/S0889-8553(05)70308-3.
CAS
PubMed
Google Scholar
Spechler SJ: Screening and surveillance for complications related to gastroesophageal reflux disease. Am J Med. 2001, 111 (Suppl 8A): 130S-136S. 10.1016/S0002-9343(01)00851-8.
PubMed
Google Scholar
Haux J: Infection and cancer. Lancet. 2001, 358: 155-156. 10.1016/S0140-6736(01)05369-7.
CAS
PubMed
Google Scholar
Xiang R, Silletti S, Lode HN, Dolman CS, Ruehlmann JM, Niethammer AG, Pertl U, Gillies SD, Primus FJ, Reisfeld RA: Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice. Clin Cancer Res. 2001, 7 (Suppl 3): 856s-864s.
CAS
PubMed
Google Scholar
Yu YA, Shabahang S, Timiryasova TM, Zhang Q, Beltz R, Gentschev I, Goebel W, Szalay AA: Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol. 2004, 22: 313-320. 10.1038/nbt937.
CAS
PubMed
Google Scholar
Cover TL, Krishna US, Israel DA, Peek RM: Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res. 2003, 63: 951-7.
CAS
PubMed
Google Scholar
Correa P, Miller MJ: Carcinogenesis, apoptosis and cell proliferation. Br Med Bull. 1998, 54: 151-62.
CAS
PubMed
Google Scholar
Radvanyi L: Discovery and immunologic validation of new antigens for therapeutic cancer vaccines. Int Arch Allergy Immunol. 2004, 133: 179-197. 10.1159/000076625.
CAS
PubMed
Google Scholar